Keyphrases
Prognostic Factors
100%
First-line Chemotherapy
100%
Renal Function Decline
100%
Metastatic Colorectal Cancer (mCRC)
100%
Estimated Glomerular Filtration Rate
83%
Bevacizumab
66%
FOLFIRI
66%
Chemotherapy Regimen
50%
Renal Function
50%
Cetuximab
33%
Proteinuria
33%
FOLFOX
33%
Disease Status
16%
Chronic Disease
16%
Body Mass Index
16%
Renal Disease
16%
Low Body Mass Index
16%
Old Age
16%
Clinical Factors
16%
Incidence Rate
16%
Therapy Choice
16%
Prognostic Effect
16%
Acute Kidney Injury
16%
Treatment Decisions
16%
First-line Regimen
16%
Chemotherapy Initiation
16%
Later-line
16%
Triplet Regimen
16%
Pharmacology, Toxicology and Pharmaceutical Science
Deterioration
100%
Retrospective Study
100%
First-Line Chemotherapy
100%
Metastatic Colorectal Cancer
100%
Bevacizumab
66%
Chemotherapy Regimens
50%
Cetuximab
33%
Proteinuria
33%
Disease
16%
Chemotherapy
16%
Chronic Disease
16%
Acute Kidney Failure
16%